Hongrong Wang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Baseline [18F]FDG PET/CT characterization of extramedullary disease and prognostic value in relapsed/refractory B-cell acute lymphoblastic leukemia treated with CAR-T cells.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 29, 2025
Impressive FDG PET/CT image of extensive peripheral nervous system involvement for T-lymphoblastic leukemia/lymphoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 06, 2025
18F-FDG PET/CT for predicting prognosis of B-cell non-Hodgkin lymphoma patients treated with chimeric antigen receptor T cells: the value of pre-infusion and M1 image.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 10, 2025
FDG PET/CT Finding in Aqueous Humor Relapse by Acute Lymphoblastic Leukemia.
Journal: Clinical nuclear medicine
Published: March 07, 2025
Pre-infusion 18 F-FDG PET/CT for Prognostic and Toxicity Prediction in B-cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-cell Therapy.
Journal: Clinical nuclear medicine
Published: December 01, 2024
Unilateral Parotid Gland Involvement of Relapsed Acute Lymphoblastic Leukemia Demonstrated by 18F-FDG PET/CT.
Journal: Clinical nuclear medicine
Published: November 17, 2024
18 F-FDG PET/CT Finding of Bilateral Breast Relapse in a Male Acute Lymphoblastic Leukemia Patient.
Journal: Clinical nuclear medicine
Published: October 28, 2024
18F-fluorodeoxyglucose positron emission tomography-compute tomography parameters for predicting the prognosis and toxicity in children and young adults with large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy.
Journal: Quantitative imaging in medicine and surgery
Published: August 20, 2024
Splenic Pseudoprogression After CAR-T Therapy Detected by 18 F-FDG PET/CT in a Refractory Diffuse Large B-Cell Lymphoma Patient.
Journal: Clinical nuclear medicine
Published: April 10, 2024
New Onset of Tuberculosis Complicating FDG PET/CT Evaluation in Patient With Recent Chimeric Antigen Receptor T-Cell Therapy.
Journal: Clinical nuclear medicine
Published: April 21, 2023
Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
Journal: Clinical nuclear medicine
Published: January 30, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026